HeartBeam, Inc. Logo

HeartBeam, Inc.

BEAT

(1.0)
Stock Price

2,43 USD

-167.01% ROA

-175.5% ROE

-3.33x PER

Market Cap.

56.311.673,00 USD

0% DER

0% Yield

0% NPM

HeartBeam, Inc. Stock Analysis

HeartBeam, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

HeartBeam, Inc. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (0%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 PBV

The stock's PBV ratio (1.22x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

3 Graham Number

The company's Graham number indicates that it is undervalued compared to its stock price, suggesting a potentially favorable investment opportunity.

4 ROE

The stock's ROE indicates a negative return (-204.09%) on shareholders' equity, suggesting poor financial performance.

5 ROA

The stock's ROA (-66.79%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

6 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

7 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (0) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

HeartBeam, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

HeartBeam, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Sell
4 Stoch RSI Sell

HeartBeam, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

HeartBeam, Inc. Revenue
Year Revenue Growth
2003 7.923.000
2004 22.231.000 64.36%
2005 30.937.728 28.14%
2006 33.922.801 8.8%
2007 72.992.186 53.53%
2008 120.454.000 39.4%
2009 140.621.000 14.34%
2010 119.924.000 -17.26%
2011 119.022.000 -0.76%
2012 111.494.000 -6.75%
2013 129.501.000 13.9%
2014 166.578.000 22.26%
2015 178.513.000 6.69%
2016 208.332.000 14.31%
2017 286.776.000 27.35%
2018 399.472.000 28.21%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

HeartBeam, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2003 4.438.000
2004 2.412.000 -84%
2005 0 0%
2006 3.630.819 100%
2007 3.781.991 4%
2008 3.999.000 5.43%
2009 5.810.000 31.17%
2010 4.897.000 -18.64%
2011 5.698.000 14.06%
2012 4.664.000 -22.17%
2013 7.338.000 36.44%
2014 7.396.000 0.78%
2015 7.111.000 -4.01%
2016 8.355.000 14.89%
2017 11.101.000 24.74%
2018 11.206.000 0.94%
2019 41.000 -27231.71%
2020 133.000 69.17%
2021 255.000 47.84%
2022 5.677.000 95.51%
2023 6.492.000 12.55%
2023 6.798.000 4.5%
2024 11.376.000 40.24%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

HeartBeam, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2003 0
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 41.917.000 100%
2009 39.153.000 -7.06%
2010 34.657.000 -12.97%
2011 35.011.000 1.01%
2012 33.422.000 -4.75%
2013 37.061.000 9.82%
2014 45.800.000 19.08%
2015 47.932.000 4.45%
2016 56.596.000 15.31%
2017 88.597.000 36.12%
2018 112.427.000 21.2%
2019 0 0%
2020 655.000 100%
2021 2.030.000 67.73%
2022 7.354.000 72.4%
2023 8.456.000 13.03%
2023 8.516.000 0.7%
2024 8.984.000 5.21%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

HeartBeam, Inc. EBITDA
Year EBITDA Growth
2003 -12.680.000
2004 -20.947.000 39.47%
2005 -11.463.257 -82.73%
2006 -4.988.441 -129.8%
2007 4.190.954 219.03%
2008 19.551.000 78.56%
2009 -9.522.000 305.32%
2010 -7.524.000 -26.56%
2011 -49.046.000 84.66%
2012 -3.430.000 -1329.91%
2013 5.214.000 165.78%
2014 444.000 -1074.32%
2015 20.384.000 97.82%
2016 30.039.000 32.14%
2017 24.249.000 -23.88%
2018 92.047.000 73.66%
2019 -294.000 31408.5%
2020 -788.000 62.69%
2021 -2.263.000 65.18%
2022 -13.031.000 82.63%
2023 -14.948.000 12.82%
2023 675.000 2314.52%
2024 -20.360.000 103.32%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

HeartBeam, Inc. Gross Profit
Year Gross Profit Growth
2003 2.259.000
2004 5.260.000 57.05%
2005 30.937.728 83%
2006 21.221.803 -45.78%
2007 47.465.768 55.29%
2008 80.541.000 41.07%
2009 91.933.000 12.39%
2010 72.432.000 -26.92%
2011 69.946.000 -3.55%
2012 65.901.000 -6.14%
2013 79.070.000 16.65%
2014 93.464.000 15.4%
2015 106.557.000 12.29%
2016 129.450.000 17.68%
2017 172.370.000 24.9%
2018 250.486.000 31.19%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

HeartBeam, Inc. Net Profit
Year Net Profit Growth
2003 -12.680.000
2004 -20.947.000 39.47%
2005 -11.463.257 -82.73%
2006 -7.644.732 -49.95%
2007 -358.071 -2034.98%
2008 9.205.000 103.89%
2009 -20.476.000 144.96%
2010 -19.860.000 -3.1%
2011 -61.422.000 67.67%
2012 -12.202.000 -403.38%
2013 -7.319.000 -66.72%
2014 -9.793.000 25.26%
2015 7.428.000 231.84%
2016 53.437.000 86.1%
2017 -15.956.000 434.9%
2018 42.820.000 137.26%
2019 -778.000 5603.86%
2020 -1.348.000 42.28%
2021 -6.593.000 79.55%
2022 -12.827.000 48.6%
2023 -13.880.000 7.59%
2023 -14.639.000 5.18%
2024 -19.824.000 26.16%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

HeartBeam, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2003 -5
2004 -7 28.57%
2005 -4 -75%
2006 -3 -100%
2007 0 0%
2008 1 0%
2009 -1 0%
2010 -1 0%
2011 -3 100%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 2 100%
2017 -1 0%
2018 1 100%
2019 0 0%
2020 0 0%
2021 -1 0%
2022 -2 100%
2023 -1 0%
2023 -1 0%
2024 -1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

HeartBeam, Inc. Free Cashflow
Year Free Cashflow Growth
2006 -3.826.395
2007 -13.288.585 71.21%
2008 -1.496.000 -788.27%
2009 -12.034.000 87.57%
2010 5.115.000 335.27%
2011 1.076.000 -375.37%
2012 -219.000 591.32%
2013 3.090.000 107.09%
2014 -3.970.000 177.83%
2015 750.000 629.33%
2016 27.952.000 97.32%
2017 10.085.000 -177.16%
2018 48.109.000 79.04%
2019 -218.000 22168.35%
2020 -600.000 63.67%
2021 -3.230.000 81.42%
2022 -9.948.000 67.53%
2023 -2.098.000 -374.17%
2023 -12.349.000 83.01%
2024 -3.560.000 -246.88%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

HeartBeam, Inc. Operating Cashflow
Year Operating Cashflow Growth
2006 -2.912.729
2007 -237.639 -1125.69%
2008 10.308.000 102.31%
2009 7.904.000 -30.41%
2010 10.362.000 23.72%
2011 5.030.000 -106%
2012 5.743.000 12.42%
2013 11.259.000 48.99%
2014 8.811.000 -27.78%
2015 14.350.000 38.6%
2016 38.851.000 63.06%
2017 23.782.000 -63.36%
2018 72.746.000 67.31%
2019 -218.000 33469.72%
2020 -600.000 63.67%
2021 -3.230.000 81.42%
2022 -9.948.000 67.53%
2023 -2.098.000 -374.17%
2023 -12.093.000 82.65%
2024 -3.550.000 -240.65%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

HeartBeam, Inc. Capital Expenditure
Year Capital Expenditure Growth
2006 913.666
2007 13.050.946 93%
2008 11.804.000 -10.56%
2009 19.938.000 40.8%
2010 5.247.000 -279.99%
2011 3.954.000 -32.7%
2012 5.962.000 33.68%
2013 8.169.000 27.02%
2014 12.781.000 36.08%
2015 13.600.000 6.02%
2016 10.899.000 -24.78%
2017 13.697.000 20.43%
2018 24.637.000 44.4%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 256.000 100%
2024 10.000 -2460%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

HeartBeam, Inc. Equity
Year Equity Growth
2003 8.000.000
2004 -2.763.000 389.54%
2006 -19.856.766 86.09%
2007 -26.865.079 26.09%
2008 150.117.000 117.9%
2009 149.353.000 -0.51%
2010 134.928.000 -10.69%
2011 77.997.000 -72.99%
2012 69.998.000 -11.43%
2013 66.829.000 -4.74%
2014 63.676.000 -4.95%
2015 75.926.000 16.13%
2016 138.914.000 45.34%
2017 250.757.000 44.6%
2018 310.485.000 19.24%
2019 -3.727.000 8430.69%
2020 -4.785.000 22.11%
2021 13.410.000 135.68%
2022 2.374.000 -464.87%
2023 15.937.000 85.1%
2023 18.629.000 14.45%
2024 8.706.000 -113.98%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

HeartBeam, Inc. Assets
Year Assets Growth
2003 22.151.000
2004 22.802.000 2.86%
2006 17.170.069 -32.8%
2007 103.039.528 83.34%
2008 165.773.000 37.84%
2009 168.322.000 1.51%
2010 156.692.000 -7.42%
2011 94.975.000 -64.98%
2012 90.010.000 -5.52%
2013 87.546.000 -2.81%
2014 124.778.000 29.84%
2015 124.143.000 -0.51%
2016 198.984.000 37.61%
2017 524.562.000 62.07%
2018 586.801.000 10.61%
2019 7.000 -8382771.43%
2020 51.000 86.27%
2021 13.998.000 99.64%
2022 4.039.000 -246.57%
2023 17.131.000 76.42%
2023 19.648.000 12.81%
2024 10.126.000 -94.04%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

HeartBeam, Inc. Liabilities
Year Liabilities Growth
2003 14.151.000
2004 25.565.000 44.65%
2006 37.026.835 30.96%
2007 129.904.607 71.5%
2008 15.656.000 -729.74%
2009 18.969.000 17.47%
2010 21.764.000 12.84%
2011 16.978.000 -28.19%
2012 20.012.000 15.16%
2013 20.717.000 3.4%
2014 61.102.000 66.09%
2015 48.217.000 -26.72%
2016 60.070.000 19.73%
2017 274.859.000 78.15%
2018 276.316.000 0.53%
2019 3.734.000 -7300%
2020 4.836.000 22.79%
2021 588.000 -722.45%
2022 1.665.000 64.68%
2023 1.194.000 -39.45%
2023 1.019.000 -17.17%
2024 1.420.000 28.24%

HeartBeam, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.64
Price to Earning Ratio
-3.33x
Price To Sales Ratio
0x
POCF Ratio
-4.71
PFCF Ratio
-4.57
Price to Book Ratio
6.47
EV to Sales
0
EV Over EBITDA
-2.66
EV to Operating CashFlow
-3.94
EV to FreeCashFlow
-3.83
Earnings Yield
-0.3
FreeCashFlow Yield
-0.22
Market Cap
0,06 Bil.
Enterprise Value
0,05 Bil.
Graham Number
2.17
Graham NetNet
0.29

Income Statement Metrics

Net Income per Share
-0.64
Income Quality
0.71
ROE
-1.21
Return On Assets
-2.77
Return On Capital Employed
-3.97
Net Income per EBT
1
EBT Per Ebit
0.97
Ebit per Revenue
0
Effective Tax Rate
0.54

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.45
Free CashFlow per Share
-0.46
Capex to Operating CashFlow
-0.03
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
-1.46
Return on Tangible Assets
-1.67
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0.01

Balance Sheet

Cash per Share
0,34
Book Value per Share
0,33
Tangible Book Value per Share
0.33
Shareholders Equity per Share
0.33
Interest Debt per Share
0
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
0.52
Current Ratio
6.83
Tangible Asset Value
0,01 Bil.
Net Current Asset Value
0,01 Bil.
Invested Capital
8651000
Working Capital
0,01 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

HeartBeam, Inc. Dividends
Year Dividends Growth

HeartBeam, Inc. Profile

About HeartBeam, Inc.

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.

CEO
Mr. Robert P. Eno
Employee
15
Address
2118 Walsh Avenue
Santa Clara, 95050

HeartBeam, Inc. Executives & BODs

HeartBeam, Inc. Executives & BODs
# Name Age
1 Mr. Timothy Cruickshank
Chief Financial Officer
70
2 Dr. Peter J. Fitzgerald FACC, M.D., Ph.D.
Member of Scientific Advisory Board & Chief Medical Officer
70
3 Mr. Kenneth Persen
Chief Technology Officer
70
4 Dr. Branislav Vajdic Ph.D.
Founder, President & Director
70
5 Mr. Robert P. Eno
Chief Executive Officer & Chief Business Officer
70
6 Ms. Richa Gujarati
Senior Vice President of Product
70
7 Mr. Richard M. Ferrari
Executive Chairman
70

HeartBeam, Inc. Competitors